Adicet Bio, Inc.
ACET
$8.26
$0.151.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.24M | -30.52M | -26.86M | -31.22M | -28.21M |
| Total Depreciation and Amortization | 1.34M | 1.47M | 1.57M | 1.66M | 1.68M |
| Total Amortization of Deferred Charges | -- | 28.00K | 0.00 | 0.00 | 15.00K |
| Total Other Non-Cash Items | 1.26M | 5.47M | 2.51M | 2.87M | 2.82M |
| Change in Net Operating Assets | -3.84M | 2.64M | 470.00K | 58.00K | -1.70M |
| Cash from Operations | -21.49M | -20.91M | -22.31M | -26.63M | -25.40M |
| Capital Expenditure | -37.00K | 10.00K | -209.00K | -47.00K | -1.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.92M | -44.55M | 17.05M | 33.00M | -1.37M |
| Cash from Investing | 18.88M | -44.54M | 16.84M | 32.95M | -2.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -150.00K | -- | -- |
| Issuance of Common Stock | -- | 75.23M | 0.00 | 267.00K | -- |
| Repurchase of Common Stock | -65.00K | 0.00 | 0.00 | 0.00 | -104.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -65.00K | 75.23M | -150.00K | 267.00K | -104.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68M | 9.79M | -5.62M | 6.59M | -28.36M |